multihance, 0.5m solution for injection
bracco imaging spa - gadobenate dimeglumine - solution for injection - 0.5 mole(s)/litre - paramagnetic contrast media; gadobenic acid
multihance 529 mg/ml solution for injection in pre-filled syringe
bracco imaging spa - gadobenate dimeglumine - solution for injection in pre-filled syringe - 529 milligram(s)/millilitre - paramagnetic contrast media; gadobenic acid
dotagraf 279.32 mg/ml solution for injection
bayer limited - gadolinium oxide; dota acid; meglumine; gadoteric acid - solution for injection - 279.32 milligram(s)/millilitre - paramagnetic contrast media; gadoteric acid
dotagraf 279.32 mg/ml solution for injection
bayer limited - gadolinium oxide; dota acid; meglumine - solution for injection - 279.32 milligram(s)/millilitre - paramagnetic contrast media; gadoteric acid
multihance injection 10 ml
dch auriga singapore - gadobenate dimeglumine; gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml; gadobenate dimeglumine 529 mg/ml
multihance injection 15 ml
dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml
multihance injection 20 ml
dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml
multihance
dexcel ltd, israel - gadobenic acid as dimeglumine salt - solution for injection - gadobenic acid as dimeglumine salt 334 mg/ml - gadobenic acid - gadobenic acid - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) indicated for: • mri of the liver for the detection of focal liver lesions in patients with known or suspected primary liver cancer (eg. hepatocellular carcinoma) or metastatic disease.• mri of the brain and spine where it improves the detection of lesions and provides diagnostic information additional to that obtained with unenhanced mri.• contrast-enhanced mr- angiography where it improves the diagnostic accuracy for detecting clinically significant steno-occlusive vascular disease in patients with suspected or known vascular disease of the abdominal or peripheral arteries.• mri of the breast, for the detection of malignant lesions in patients where breast cancer is known or suspected on the basis of previous mammography or ultrasound results
magnevist injection 469 mgml
bayer (south east asia) pte ltd - gadopentetic acid, dimeglumine salt - injection - 469 mg/ml - gadopentetic acid, dimeglumine salt 469 mg/ml
magnevist
bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - gadopentate dimeglumine - solution for injection - gadopentate dimeglumine - contrast media